Literature DB >> 6165738

Hyperosmolar triggering of histamine release from human basophils.

S R Findlay, A M Dvorak, A Kagey-Sobotka, L M Lichtenstein.   

Abstract

Idiopathic reactions occurring during the infusion of hyperosmolar solutions, such as radiocontrast dyes, cause a significant number of deaths each year. These reactions are similar to those which follow mediator release during allergen-induced anaphylaxis. In attempting to explain these nonimmunologic reactions, we examined the direct effect of hyperosmolarity on normal human basophils with emphasis on release induced by mannitol. The cells of all donors released histamine in vitro in response to hyperosmolar (0.2-0.7 M) solutions of a number of solutes including mannitol. That this was not a toxic process was supported by a number of criteria, including inhibition of release by excess stimulus at 37 degrees C and a lack of release at 4 degrees C. Furthermore, electron microscopic studies revealed that hyperosmolar stimulation did not disrupt the cell membrane or lead to any signs of cytotoxicity. In contrast to antigen-stimulated release, where granules fuse only with the cell membrane, granules in mannitol-stimulated cells, in addition to fusing with the cell membrane, may also be extruded into a common intracellular sac before exteriorization. Characteristics similar to antigen-induced histamine release included the time-course for release, inhibition by drugs that modify phospholipid metabolism, p-bromophenacyl bromide, and eicosa-5,8,11,14-tetraynoic acid, and augmentation of release by deuterium oxide (D(2)O). The release process differed from antigen-induced release by a number of criteria, including independence from immunoglobulin (Ig)E-related mechanisms, insensitivity to agonists that elevate intracellular cyclic AMP, minimal dependence on extracellular calcium, lack of inhibition by 2-deoxyglucose and theophylline, and a temperature optimum of 32 degrees C. We conclude that this noncytotoxic hyperosmolar release process is different from IgE-mediated secretory events and may well play a role in the idiopathic reactions which occur secondary to the infusion of hyperosmolar solutions in man.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165738      PMCID: PMC370734          DOI: 10.1172/jci110195

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  An experimental basis for histamine release in contrast material reactions.

Authors:  E C Lasser; A J Walters; J H Lang
Journal:  Radiology       Date:  1974-01       Impact factor: 11.105

2.  Loss of cell surface material from peritoneal exudate cells associated with lymphocyte-mediated inhibition of macrophage migration from capillary tubes.

Authors:  A M Dvorak; M E Hammond; H F Dvorak; M J Karnovsky
Journal:  Lab Invest       Date:  1972-12       Impact factor: 5.662

3.  Use of cationized ferritin as a label of negative charges on cell surfaces.

Authors:  D Danon; L Goldstein; Y Marikovsky; E Skutelsky
Journal:  J Ultrastruct Res       Date:  1972-03

4.  Histidine at the active site of phospholipase A2.

Authors:  J J Volwerk; W A Pieterson; G H de Haas
Journal:  Biochemistry       Date:  1974-03-26       Impact factor: 3.162

5.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

6.  Acute reactions to urographic contrast media.

Authors:  P Davies; M B Roberts; J Roylance
Journal:  Br Med J       Date:  1975-05-24

7.  Metabolism of [14C]arachidonic acid by human platelets.

Authors:  T K Bills; J B Smith; M J Silver
Journal:  Biochim Biophys Acta       Date:  1976-02-23

8.  Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B.

Authors:  E Gillespie; L M Lichtenstein
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

9.  The ultrastructural basis of capillary permeability studied with peroxidase as a tracer.

Authors:  M J Karnovsky
Journal:  J Cell Biol       Date:  1967-10       Impact factor: 10.539

10.  STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN.

Authors:  L M LICHTENSTEIN; A G OSLER
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Anaphylactoid reactions to radiocontrast material.

Authors:  P Lieberman
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

2.  Cardiac mast cells: partial purification of guinea-pig atrial mast cells and release from them of histamine and leukotriene C4 by immune and non-immune stimuli.

Authors:  E S Assem; F R Machado; N S Ghanem
Journal:  Agents Actions       Date:  1986-04

3.  The effects of urine on mast cells and smooth muscle of the human ureter.

Authors:  L Ugaily-Thulesius; O Thulesius
Journal:  Urol Res       Date:  1988

4.  The effects of rapid infusions of saline and mannitol on cerebral blood volume and intracranial pressure in dogs.

Authors:  P Ravussin; D P Archer; E Meyer; M Abou-Madi; L Yamamoto; D Trop
Journal:  Can Anaesth Soc J       Date:  1985-09

5.  Exercise induced rhinorrhoea.

Authors:  S O'Hickey; P Christie; T Lee
Journal:  BMJ       Date:  1988-11-05

Review 6.  Radiocontrast reactions.

Authors:  P Lieberman; R L Siegle; G Treadwell
Journal:  Clin Rev Allergy       Date:  1986-05

Review 7.  Exercise-induced asthma.

Authors:  P A Eggleston
Journal:  Clin Rev Allergy       Date:  1983-03

Review 8.  Basophils in human disease.

Authors:  E B Mitchell; P W Askenase
Journal:  Clin Rev Allergy       Date:  1983-09

9.  Hyperosmolarity selectively enhances IgE-receptor-mediated histamine release from human basophils.

Authors:  B W Nielsen; T Bjerke; T M Damsgaard; T Herlin; K Thestrup-Pedersen; P O Schiøtz
Journal:  Agents Actions       Date:  1992-03

10.  Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.

Authors:  A G Togias; R M Naclerio; D Proud; J E Fish; N F Adkinson; A Kagey-Sobotka; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.